Skip to main content

Fifth Eye™, a leading provider of real-time AI-based clinical analytics today announced that its Board of Directors has appointed Andrew Malcolmson as its new President and Chief Executive Officer. Andrew replaces Jen Baird who founded and led Fifth Eye from conception through product development, FDA clearance, and initial commercial release of their Analytic for Hemodynamic Instability (AHI) System.

Read Article